Sort by
Refine Your Search
-
Where to apply Website https://careers.epfl.ch/job/Fribourg-Postdoctoral-Scholar-Opening-in-Indoor-Air… Requirements Research FieldEngineeringEducation LevelPhD or equivalent Additional Information Work
-
conducts applied and theoretical research on the economics and politics of sustainable development, as well as the policies to achieve it. More information at: https://www.epfl.ch/labs/pasu/ . We are looking
-
: https://www.epfl.ch/labs/hobel/ For more information about Prof. Dusan Licina: https://people.epfl.ch/dusan.licina For more information about EPFL: https://www.epfl.ch/en/ For more information about Smart
-
the Academy of Management Journal from 2023 to 2025. The Chair has a collegial, collaborative environment, and supports postdoctoral researchers toward successful job placement in professorial and academic
-
opportunities for technology transfer and innovation Competitive salary and excellent working conditions - more information can be found on our website (https://www.epfl.ch/campus/services/human-resources/en
-
the earth sciences. NCCR Genesis does not aim to provide answers in all fields, but to drive innovative research and achieve decisive progress. Details on NCCR Genesis are available on its website https
-
Foster ([email protected]) - https://laser.epfl.ch/ Contract Start Date : 01.12.2026, or to be determined Activity Rate : 100.00 Contract Type: CDD Duration: 1 year, renewable Reference: 2464
-
than 18,500 people, including over 14,000 students and 4,000 researchers from more than 120 different countries. Postdoc in ML-Based Co-Design at EPFL Mission The EPFL computer vision lab (https://www.epfl.ch
-
information can be found on https://laser.epfl.ch/. Contract Start Date : 01.12.2026, or to be determined Activity Rate : 100.00 Contract Type: CDD Duration: 1 year, renewable (project duration permitting
-
protocols. In close collaboration with the lab of George Coukos (https://agora-cancer.ch/laboratory/coukos-lab/ ), we will derive protocols enabling rapid expansion of cancer-specific, autologous TILs